| 000 | 01856 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515070323.0 | ||
| 264 | 0 | _c20090420 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1671-4083 | ||
| 024 | 7 |
_a10.1111/j.1745-7254.2007.00580.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNa, Tao | |
| 245 | 0 | 0 |
_aAbrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017. _h[electronic resource] |
| 260 |
_bActa pharmacologica Sinica _cJun 2007 |
||
| 300 |
_a773-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xchemistry |
| 650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xgenetics |
| 650 | 0 | 4 |
_aBerberine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCardiomyopathies _xchemically induced |
| 650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aEndothelin-Converting Enzymes |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetalloendopeptidases _xgenetics |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xcytology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xgenetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aReperfusion |
| 650 | 0 | 4 |
_aSarcoplasmic Reticulum Calcium-Transporting ATPases _xmetabolism |
| 650 | 0 | 4 |
_aTacrolimus Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aThyroxine _xadverse effects |
| 650 | 0 | 4 |
_aVentricular Fibrillation _xmetabolism |
| 700 | 1 | _aHuang, Zhi-Jiang | |
| 700 | 1 | _aDai, De-Zai | |
| 700 | 1 | _aZhang, Yuan | |
| 700 | 1 | _aDai, Yin | |
| 773 | 0 |
_tActa pharmacologica Sinica _gvol. 28 _gno. 6 _gp. 773-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1745-7254.2007.00580.x _zAvailable from publisher's website |
| 999 |
_c17051351 _d17051351 |
||